08/21/2026
A new study from the lab of Ashutosh Mangalam, PhD and researchers at the College of Dentistry and Dental Clinics, University of Iowa and UIowa Immunology Graduate Program reveals that an inflammatory molecule linked to multiple sclerosis could change the disease by not only by acting on immune cells, but also by reshaping the bacteria living in the gut.
These findings raise the possibility that future microbiome-directed approaches could complement therapies targeting inflammatory pathways by promoting beneficial bacteria and strengthening regulatory immune responses.
Read more about the study on our website:
Mangalam lab discovers how an inflammatory signal reshapes the gut microbiome to influence neuroinflammation.